Public Employees Retirement Association of Colorado’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.27M Buy
208,471
+194,650
+1,408% +$4.28M 0.02% 420
2026
Q1
$308K Hold
13,821
﹤0.01% 1238
2025
Q4
$369K Hold
13,821
﹤0.01% 1137
2025
Q3
$295K Hold
13,821
﹤0.01% 1252
2025
Q2
$298K Hold
13,821
﹤0.01% 1239
2025
Q1
$230K Hold
13,821
﹤0.01% 1366
2024
Q4
$254K Hold
13,821
﹤0.01% 1384
2024
Q3
$213K Hold
13,821
﹤0.01% 1500
2024
Q2
$225K Sell
13,821
-1,527
-10% -$24.6K ﹤0.01% 1429
2024
Q1
$284K Sell
15,348
-133
-0.9% -$3.29K ﹤0.01% 1327
2023
Q4
$485K Sell
15,481
-1,853
-11% -$44.3K ﹤0.01% 1021
2023
Q3
$361K Sell
17,334
-999
-5% -$27.1K ﹤0.01% 1156
2023
Q2
$439K Hold
18,333
﹤0.01% 1112
2023
Q1
$345K Hold
18,333
﹤0.01% 1264
2022
Q4
$292K Hold
18,333
﹤0.01% 1401
2022
Q3
$300K Hold
18,333
﹤0.01% 1344
2022
Q2
$258K Hold
18,333
﹤0.01% 1474
2022
Q1
$444K Hold
18,333
﹤0.01% 1201
2021
Q4
$428K Hold
18,333
﹤0.01% 1356
2021
Q3
$305K Hold
18,333
﹤0.01% 1539
2021
Q2
$447K Hold
18,333
﹤0.01% 1314
2021
Q1
$473K Hold
18,333
﹤0.01% 1221
2020
Q4
$980K Hold
18,333
﹤0.01% 758
2020
Q3
$756K Hold
18,333
﹤0.01% 790
2020
Q2
$889K Hold
18,333
0.01% 703
2020
Q1
$775K Hold
18,333
0.01% 689
2019
Q4
$784K Hold
18,333
﹤0.01% 796
2019
Q3
$660K Hold
18,333
﹤0.01% 880
2019
Q2
$490K Hold
18,333
﹤0.01% 1057
2019
Q1
$492K Hold
18,333
﹤0.01% 1053
2018
Q4
$296K Hold
18,333
﹤0.01% 1295
2018
Q3
$381K Hold
18,333
﹤0.01% 1297
2018
Q2
$280K Sell
18,333
-3,723
-17% -$66.4K ﹤0.01% 1451
2018
Q1
$496K Buy
22,056
+7
+0% +$194 ﹤0.01% 1079
2017
Q4
$664K Buy
22,049
+679
+3% +$21.7K ﹤0.01% 993
2017
Q3
$805K Hold
21,370
0.01% 881
2017
Q2
$596K Buy
21,370
+4
+0% +$119 ﹤0.01% 1035
2017
Q1
$735K Sell
21,366
-39
-0.2% -$1.38K 0.01% 932
2016
Q4
$617K Sell
21,405
-11
-0.1% -$291 ﹤0.01% 1022
2016
Q3
$681K Sell
21,416
-949
-4% -$32.2K 0.01% 953
2016
Q2
$726K Buy
22,365
+914
+4% +$30.6K 0.01% 934
2016
Q1
$600K Buy
21,451
+1,596
+8% +$34.8K ﹤0.01% 1044
2015
Q4
$708K Hold
19,855
0.01% 951
2015
Q3
$657K Hold
19,855
0.01% 1018
2015
Q2
$832K Sell
19,855
-3,685
-16% -$143K 0.01% 986
2015
Q1
$767K Hold
23,540
0.01% 1040
2014
Q4
$747K Sell
23,540
-7,024
-23% -$199K 0.01% 1051
2014
Q3
$757K Hold
30,564
0.01% 1031
2014
Q2
$690K Buy
+30,564
New +$638K 0.01% 1112

Other funds holding ACAD

Public Employees Retirement Association of Colorado's ACAD Position: Q2 2026 in Review

Public Employees Retirement Association of Colorado increased its Acadia Pharmaceuticals (ACAD) stake by 1,408% in Q2 2026, buying an estimated $4.28M and bringing the position to 208,471 shares worth $5.27M. The position accounts for 0.02% of the portfolio, ranked #420.

Public Employees Retirement Association of Colorado first reported a position in ACAD in Q2 2014 and has held it in 49 quarters since. 186 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

  • Public Employees Retirement Association of Colorado held 208,471 shares of Acadia Pharmaceuticals worth $5.27M as of Q2 2026.
  • Public Employees Retirement Association of Colorado bought 194,650 Acadia Pharmaceuticals shares in Q2 2026, an estimated $4.28M.
  • Acadia Pharmaceuticals made up 0.02% of Public Employees Retirement Association of Colorado's portfolio in Q2 2026, its #420 holding.
  • Public Employees Retirement Association of Colorado first reported a position in Acadia Pharmaceuticals in Q2 2014 and has held it in 49 quarters since.
  • 186 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on Public Employees Retirement Association of Colorado's 13F filing for Q2 2026, filed 11 Aug 2026.